Novo Nordisk on Tuesday received a broker downgrade, with the analysts arguing that its status as a duopoly in both diabetes and weight loss are under threat.
FlashNews:
Gingrich: ‘If the election were in May, Republicans would lose’
Raven Austen’s Backlit A Collection Delivers a Powerful Testimony of Redemption, Faith, and Grace
The Missing Lieutenant: A Master Conman Meets His Match in Barbara G. Kruk’s Electrifying New Thriller
Concept Health Completes New Medical Centre Fitout for Mooroolbark Station Medical Centre
TEELX Announces Strategic Partnership to Advance AI-Driven Quantitative Trading
HA.TS COMMERCE CORP Expands Global Smart Retail Vision Under Leadership of Andrew M. Hayashi
New App ‘Lunona’ Transforms Android TVs into an Essential Caregiver Tool, Bridging the Tech Gap for Senior Reminders
Construction Financing Experience Highlights Importance of Transparency in Draw-Based Lending Structures
Deyang Rata introduces 500kW dual-voltage load bank to support generator testing applications
Deyang Rata announces 125kW 600Vac AC resistive load bank for industrial energy storage system testing
True North Launches AI-Powered Owner-Operator Carrier Platform to Maximize Independent Trucking Profitability
Smart Vend Group Ltd. (SVGAPP) Reshapes the Retail Industry Landscape
Smart Vend Group Ltd. (SVGAPP) Powers Scalable Growth with Intelligent Retail Infrastructure
Smart Vend Group Ltd (SVGAPP) Drives the Implementation of Smart Retail Models
Smart Vend Group Ltd (SVGAPP) Leads the Digital Transformation of the Retail Industry
Smart Vend Group Ltd (SVGAPP) Opens a New Path for Retail Entrepreneurship
Sean Kirtz: Developing Elite Wrestlers for Peak Performance
Where-R-You Introduces GPS Patent -Enabled Insoles Designed to Enhance Personal Safety and Location Awareness
SEVENTEEN TO A MAN BY DR. WILLIAM RANKIN BRINGS A POWERFUL LIFE STORY OF SURVIVAL, SERVICE, AND TRANSFORMATION
Home » Ozempic maker Novo Nordisk gets another downgrade. The end’s in sight for its duopoly status, says TD Cowen.